| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.13 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.074 | 0.09 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.08 | 0.09 |